Exclusive: With backing of Ravens owner, Blackbird launches with $100M to boost Baltimore’s biotech scene
A life sciences accelerator called Blackbird Laboratories has $100 million to spend to turn Baltimore into a biotech hub.
Blackbird was founded at the start of this year with the backing of Baltimore Ravens owner Steve Bisciotti’s family foundation. So far, Blackbird has looked at about 80 to 100 proposals and funded five programs, Blackbird CEO Matt Tremblay told Endpoints News.
Baltimore has had a few notable biotech success stories, such as Thrive Earlier Detection (acquired by Exact Sciences in 2020) and Personal Genome Diagnostics (acquired by Labcorp in 2022), but Tremblay said he hopes to support a “Kendall Square-like phenomena.” He’s looking to back research ideas that ultimately become biotech startups based in Baltimore. Today, many startups in the area wind up in suburbs like Rockville, MD, which “lose that connectivity” with being directly next to a university like Johns Hopkins, Tremblay said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.